2014-004163-21
Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Children In Africa
Pfizer Inc·EU Clinical Trials Register
Study focus
- Disease/Condition
- Malaria
Sponsor & location
- Primary sponsor
- Pfizer Inc
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
1. Peripheral blood smear positive for mixed infection with multiple Plasmodium species.
ICD-10 classifications
Unspecified malariaPlasmodium malariae malariaPlasmodium falciparum malariaOther parasitologically confirmed malariaPlasmodium ovale malaria
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2014-004163-21
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2014-004163-21 through Pure Global AI's free database. This phase not specified trial is sponsored by Pfizer Inc and is currently status unknown. The study focuses on Malaria.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.